At the request of Pharming Technologies B.V. (“Pharming”), a wholly-owned subsidiary of Pharming Group N.V., which, following its public offer to the shareholders of Abliva AB (publ) (“Abliva”), holds ...

The shareholders of Abliva AB (publ), corporate identity number 556595-6538, (“the Company or “Abliva”) are hereby convened to the Annual General Meeting, held at 1 p.m. on Thursday, 23 May 2024 at Me ...

The shareholders of Abliva AB (publ), corporate identity number 556595-6538, (the “Company”), are hereby convened to the Extraordinary General Meeting (the “EGM”) to be held at 3 p.m. on Tuesday 26 Ma ...